Publications by authors named "David Busquets"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

3,413

Total Likes

119

Extended Reach

149,837

Social Features

53
F
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, Ruth de Francisco, Francisco Javier García-Alonso, David Busquets

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU.
Jordina Llaó, Míriam Mañosa, Eduardo Martín-Arranz, Yamile Zabana, Mercè Navarro-Llavat, David Busquets

J Crohns Colitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Míriam Mañosa, Margalida Calafat, Elena Ricart, Pilar Nos, Eva Iglesias, David Busquets

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity.
Hugo Tejera-Pérez, Alejandro Velasco-Ruiz, María Chaparro, Rocío Núñez-Torres, Guillermo Pita, David Busquets

Biomed Pharmacother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU.
María José Casanova, Cristina Rubín de Célix, Sabino Riestra, Alfredo J Lucendo, José Manuel Benítez, David Busquets

Aliment Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
Laura Palomino, Marta Velasco Rodríguez-Belvís, María José Casanova, Eduardo Leo-Carnerero, Cristina Calviño-Suárez, David Busquets

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History.
Eduard Brunet-Mas, Anna Selva, Francesc Bas-Cutrina, Anna Brujats, Berta Caballol, David Busquets

Clin Transl Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Javier P Gisbert, María G Donday, Sabino Riestra, Alfredo J Lucendo, José-Manuel Benítez, David Busquets

Gut· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
Margalida Calafat, Carles Suria, Francisco Mesonero, Ruth de Francisco, Carmen Yagüe Caballero, David Busquets

Am J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU.
María José Casanova, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, David Busquets

Dig Liver Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.
Carlos González-Muñoza, Margalida Calafat, Javier P Gisbert, Eva Iglesias, Miguel Mínguez, David Busquets

Postgrad Med J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Juliana Salazar, Esther Garcia-Planella, Agnès Fernández-Clotet, Maria Esteve, Javier P Gisbert, David Busquets

Br J Clin Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
Aleix Lluansí, Marc Llirós, Robert Carreras-Torres, Anna Bahí, Montserrat Capdevila, David Busquets

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lichen planus of the esophagus: a case report.
Elvira Guarner, Fatimetu Mohamed, David Busquets, Begoña Fuertes Negro, Rosa Ortiz

Front Med (Lausanne)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.
Dulce Momblan, Antonio Z Gimeno Garcia, David Busquets, Diego Juzgado, Javier García Lledó

Am J Gastroenterol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.
Carme Loras, Pablo Ruiz-Ramirez, Juan Romero, Xavier Andújar, Josep Bargallo, David Busquets

Trials· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Míriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, María Dolores Martín-Arranz, Noemí Manceñido, David Busquets

Dig Liver Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
Yamile Zabana, Ignacio Marín-Jiménez, Iago Rodríguez-Lago, Isabel Vera, María Dolores Martín-Arranz, David Busquets

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, Javier González García, Laura Ramos, David Busquets

Inflamm Bowel Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental and genetic evidence for the impact of and expression and variation in inflammatory bowel disease.
Sergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, Alejandra Leyton-Pereira, Rebeca Gutiérrez-Cózar, David Busquets

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
Manuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, María Pilar Soto, Marta Calvo, David Busquets

J Crohns Colitis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, Javier González García, Laura Ramos, David Busquets

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, Abundance, and Virulence of Adherent-Invasive in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease.
Mireia López-Siles, Carla Camprubí-Font, Eva M Gómez Del Pulgar, Miriam Sabat Mir, David Busquets

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Busquets

Front Med (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis